K233986 is an FDA 510(k) clearance for the BD Phoenix™ Automated Microbiology System - GN Ciprofloxacin (0.0156–4 µg/mL). This device is classified as a System, Test, Automated, Antimicrobial Susceptibility, Short Incubation (Class II - Special Controls, product code LON).
Submitted by Becton, Dickinson and Company (Sparks, US). The FDA issued a Cleared decision on March 15, 2024, 88 days after receiving the submission on December 18, 2023.
This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.1645.
| 510(k) Number | K233986 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | December 18, 2023 |
| Decision Date | March 15, 2024 |
| Days to Decision | 88 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | LON — System, Test, Automated, Antimicrobial Susceptibility, Short Incubation |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 866.1645 |